Lion's Mane Bioactive Compounds
30 years
The chemical structure of hericenone A and B — the foundational reference compounds in hericenone research — was incorrectly drawn for 30 years until a 2021 total synthesis by Kobayashi and colleagues identified the error and revised the structure, with implications for how we understand the entire compound family.
Kobayashi et al., Journal of Organic Chemistry, 2021
23.5 pg/mL
NGF induced by hericenone C in astrocyte cells; hericenone H produces 45.1 pg/mL — nearly double (Lai et al., 2013)
ERK1/2 pathway
Martínez-Mármol 2023 discovered hericerin derivatives activate this neurotrophic pathway directly in hippocampal neurons — no NGF protein required
Mori 2009 RCT
n=30 MCI patients, 16 weeks: significant cognitive improvement vs. placebo (p<0.001) with Lion's Mane extract
Kobayashi et al., Journal of Organic Chemistry, 2021
View as image ↗Hericenone C is one of eight related aromatic compounds found exclusively in the fruiting body of Hericium erinaceus, the mushroom known as Lion's Mane. It was first isolated by Kawagishi and colleagues in 1991 as part of a chemical survey that also identified hericenones A and B. Those early papers established the basic structure: a geranyl-resorcinol meroterpenoid, meaning a compound built from a resorcinol (aromatic) backbone connected to a geranyl (terpenoid) side chain.
What makes hericenone C scientifically significant is what it does in brain cells. A 2008 study by Hasegawa and colleagues demonstrated that Hericium erinaceus extract induces nerve growth factor (NGF) secretion in human astroglial cells, establishing the cellular mechanism that the entire field of hericenone research has since expanded upon.[1] Hericenone C is one of the primary compounds responsible for that NGF-stimulating activity.
This article focuses on hericenone C specifically: how it works, what the quantitative evidence looks like, and what two discoveries in 2021 and 2023 changed about how researchers understand it. For the broader comparison between hericenones and erinacines, see Hericenones and Erinacines: Lion's Mane's Brain-Boosting Compounds. For the bioactive compound context, hericenones sit within the broader picture of how medicinal mushrooms produce specific pharmacologically active molecules.
Key Takeaways
- Hericenone C is an aromatic meroterpenoid found only in Lion's Mane fruiting bodies that stimulates nerve growth factor (NGF) synthesis in astrocyte brain cells via MEK/ERK and PI3K/Akt signaling pathways (Lai et al., 2013)
- Quantitatively, hericenone C produces 23.5 pg/mL of NGF in astrocyte cells, while hericenone H produces 45.1 pg/mL — nearly double; hericenone C is not the most potent NGF-inducer in the family (Lai et al., 2013)
- When combined with a low dose of exogenous NGF (5 ng/mL), hericenone-induced neurite outgrowth matched the effect of 50 ng/mL NGF alone, showing synergy between hericenones and the NGF protein (Lai et al., 2013)
- The chemical structures of hericenones A and B were incorrectly characterized in 1991 and not corrected for 30 years — a 2021 total synthesis by Kobayashi and colleagues identified the structural error (meta vs. ortho carbonyl position), with implications for the C-H subfamily structures
- A 2023 study by Martínez-Mármol and colleagues found that hericerin derivatives activate a pan-neurotrophic ERK1/2 signaling pathway directly in hippocampal neurons — independent of NGF protein secretion — improving spatial memory in rodents
- A 2025 interdisciplinary study (Wang et al.) used LC-MS/MS with synthetic authentic standards to confirm all known hericenones in fruiting body extracts and mapped their biosynthetic intermediates for the first time
What Hericenone C Is: A Working Definition
Hericenone C is an oxygenated aromatic meroterpenoid isolated from the fruiting body of Hericium erinaceus. First isolated by Kawagishi in 1991, it stimulates nerve growth factor (NGF) synthesis in astrocyte cells by activating MEK/ERK and PI3K/Akt signaling pathways. It belongs to a family of eight related hericenone compounds (A through H) found exclusively in Lion's Mane fruiting bodies, not in mycelium.
The name "meroterpenoid" describes the compound's chemical architecture: it is partly terpenoid (built from isoprene units, like the geranyl side chain) and partly polyketide or shikimate-derived (the resorcinol aromatic ring). This hybrid structure gives hericenones their distinctive physical properties, including the low molecular weight and fat-solubility that allows them to cross cell membranes and potentially the blood-brain barrier by passive diffusion.
The resorcinol core of hericenone C carries two hydroxyl groups at positions 1 and 3 on the aromatic ring. The geranyl side chain attaches to the ring through a carbon linkage, and the compound carries a long aliphatic chain with an aldehyde group. This chemical structure, verified and revised in 2021, is what enables hericenone C to interact with specific signaling proteins in astrocyte cells.
NGF: What It Is and Why Brain Cells Depend on It
Nerve growth factor is a protein the brain produces to support the survival, maintenance, and growth of neurons. It belongs to the neurotrophin protein family and plays a specific role in supporting two types of neurons: sensory neurons (which transmit signals from the body to the brain) and cholinergic neurons in the basal forebrain (which are involved in memory formation and are among the first neurons affected in Alzheimer's disease).
Neurons express surface proteins called TrkA receptors. When NGF binds to TrkA, it activates intracellular signaling cascades, primarily through the MAPK/ERK and PI3K/Akt pathways, that promote neuron survival, dendrite growth, and axon elongation. Without adequate NGF stimulation, neurons atrophy and eventually die. The basal forebrain cholinergic neurons are especially dependent on NGF because they receive NGF produced by hippocampal and cortical cells via retrograde transport, meaning NGF made in one brain region travels backward along axons to support neurons elsewhere.
The relevance of NGF to Lion's Mane research is that NGF itself cannot be administered as a supplement — it is a large protein that does not cross the blood-brain barrier. Small molecules that stimulate NGF production inside the brain, however, can potentially address this. Hericenone C belongs to the class of molecules that stimulate this synthesis internally rather than delivering NGF from outside.
How Hericenone C Stimulates NGF Synthesis: The Astrocyte Mechanism
The cellular mechanism was established in a 2008 study by Hasegawa and colleagues using 1321N1 human astroglial cells, a human-derived astrocyte cell line.[1] Astrocytes are non-neuronal brain cells that provide structural and chemical support to neurons. Among their functions is the production of neurotrophic factors including NGF, which they secrete into the local environment where neurons can then absorb it.
When Hericium erinaceus extract was applied to the 1321N1 astrocyte cells, NGF secretion increased measurably. The implication is that the active compounds, including hericenone C, were interacting with signaling proteins in the astrocyte cells that regulate NGF gene expression and protein secretion.
A 2013 study by Lai and colleagues went further, isolating individual hericenone compounds and testing each for NGF-inducing activity, including signaling pathway identification.[2] The Lai data established the specific pathways involved: MEK/ERK and PI3K/Akt. These are well-characterized intracellular signaling cascades.
MEK/ERK (mitogen-activated protein kinase/extracellular signal-regulated kinase) is a chain of kinase enzymes that relay signals from the cell surface to the nucleus, where they affect gene expression. When this pathway is activated by hericenone C, the result is increased transcription of the NGF gene in astrocytes and ultimately more NGF protein secreted into the surrounding environment.
PI3K/Akt (phosphoinositide 3-kinase/protein kinase B) is a parallel signaling cascade primarily associated with cell survival and growth. Its activation by hericenone C likely contributes to the sustained NGF production and the downstream neurite outgrowth observed in the cell culture experiments.
The Numbers: How Much NGF Does Hericenone C Actually Produce?
The Lai 2013 study provides the clearest quantitative comparison of NGF output across the hericenone family.[2]
In the astrocyte cell model, hericenone C produced 23.5 pg/mL of NGF. Hericenone H produced 45.1 pg/mL. Hericenones D and E produced intermediate amounts (around 10–14 pg/mL in the same conditions). For context, the baseline NGF secretion in untreated cells was substantially lower, and exogenous NGF was added at 50 ng/mL (50,000 pg/mL) for the comparison condition — meaning the hericenone-induced NGF levels are modest by comparison to direct NGF protein application.
The more revealing finding from Lai 2013 is what happened when the two approaches were combined: cells treated with a low dose of exogenous NGF (5 ng/mL) plus hericenone extract showed neurite outgrowth equivalent to cells receiving 50 ng/mL NGF alone.[2] This 10-fold amplification effect suggests hericenone C is not simply adding NGF to the system but sensitizing or synergizing with the NGF signaling pathway in a way that amplifies each unit of NGF protein's effect.
This synergy observation is important for interpreting the evidence level honestly: the cell-culture concentrations at which hericenone C produces these effects may not be achievable in human brain tissue after oral supplementation. Bioavailability, gut absorption, and blood-brain barrier penetration all reduce the amount of any compound that actually reaches astrocytes in vivo. The in vitro data establishes mechanism and potency hierarchy; it does not establish clinical dose-response in humans.
The 2021 Correction: 30 Years of Wrong Structure Data
One of the most unusual aspects of hericenone research history is that the foundational structures — hericenones A and B, first characterized in 1991 — were drawn incorrectly, and no one caught the error for three decades.
The error concerned the position of a carbonyl group (a carbon-oxygen double bond) relative to a phenolic hydroxyl group on the aromatic ring. The original 1991 papers placed the carbonyl at the benzylic position in an ortho (adjacent) relationship to the phenolic hydroxyl. This structure was reproduced in every subsequent review and cited in hundreds of papers.
In 2021, Kobayashi and colleagues performed the total synthesis of hericenones C through H — meaning they built the molecules from simple starting materials, step by step, and verified the structure at each stage through spectroscopic analysis.[3] When the synthesized compound's nuclear magnetic resonance (NMR) spectrum did not match the natural compound's published NMR data, they investigated the discrepancy and found the structural assignment for hericenones A and B had been incorrect. The correct structure places the carbonyl in the meta position relative to the phenolic hydroxyl.
This correction matters for two reasons. First, it means that structure-activity relationship studies published before 2021 that relied on the original structural assignments for hericenones A and B may have drawn incorrect conclusions about which structural features are responsible for NGF activity. Second, and more practically, total synthesis confirmation means that synthetic hericenones are now available as authentic reference standards, which is what enabled the Wang 2025 LC-MS/MS characterization work.
Kobayashi's group also synthesized derivatives with modified structures and tested their neuroprotective effects, finding that some synthetic variants showed comparable or superior activity to the natural compounds.[3] This opens the door to rational design of hericenone-inspired therapeutic molecules with optimized pharmacological properties.
The 2023 Discovery: A Pan-Neurotrophic Pathway That Works Without NGF Protein
The received mechanism for hericenone C through 2022 was: compound stimulates astrocyte NGF production, NGF is secreted, NGF binds to TrkA receptors on neurons, TrkA activates intracellular signaling, neurons grow and survive. Hericenone C was essentially a remote-control switch for the NGF pathway, operating through an intermediary (astrocyte-secreted NGF protein).
A 2023 study by Martínez-Mármol and colleagues upended this model for at least some hericenone-related compounds.[4]
Martínez-Mármol's team tested hericerin derivatives — compounds structurally related to the hericenone family — directly on central hippocampal neurons rather than on astrocytes. The finding was that these compounds activated a pan-neurotrophic signaling pathway in the neurons themselves, converging on ERK1/2 (extracellular signal-regulated kinase 1 and 2), without requiring NGF protein to be present.
"Pan-neurotrophic" means the compounds activated multiple neurotrophic pathways simultaneously. ERK1/2 is activated by several neurotrophin receptors (TrkA for NGF, TrkB for BDNF, TrkC for NT-3), so activating ERK1/2 directly may produce effects normally associated with all three neurotrophins at once, not just NGF. The study further found that these direct neuronal effects translated to improved spatial memory performance in rodents.
This discovery matters because it changes the mechanism story from "hericenones make more NGF, which then works on neurons" to "hericenones (or related compounds) may act directly on neurons via ERK1/2, producing broader neurotrophic effects than previously understood." The two mechanisms are not mutually exclusive — compounds may stimulate astrocyte NGF production AND activate neuronal ERK1/2 directly.
A 2023 systematic review by Phan and colleagues, synthesizing the full evidence base on neurotrophic and neuroprotective effects of Hericium erinaceus, noted the Martínez-Mármol finding as a key update requiring integration into the mechanistic understanding of how Lion's Mane supports brain function.[8]
Where Hericenone C Is Found and How to Extract It
Hericenone C is found exclusively in the fruiting body of Hericium erinaceus. It is not present in mycelium. The reason for this tissue-specific distribution lies in gene expression: the biosynthesis enzymes responsible for assembling hericenones from their precursors are expressed in the fruiting body developmental stage, not during the mycelial growth phase.
A 2025 interdisciplinary study by Wang and colleagues used liquid chromatography-tandem mass spectrometry (LC-MS/MS) with synthetic authentic standards (the Kobayashi 2021 total synthesis made these available) to identify and confirm all known hericenones C-H in Lion's Mane fruiting body extracts.[5] They also identified biosynthetic intermediates, providing experimental evidence for the pathway from resorcinol precursor to final hericenone structures.
The Wang 2025 paper further identified n-hexane fractionation as the optimal extraction method for hericenone recovery. This is consistent with the fat-solubility of the hericenone compounds: n-hexane is a non-polar solvent that selectively concentrates lipophilic compounds. Alcohol extraction (ethanol) also captures hericenones, and dual extraction products that use an alcohol stage alongside hot water should contain hericenones from the alcohol fraction.
Products derived from mycelium grown on grain substrates will not contain hericenones regardless of extraction method. Hericenones are a reliable quality marker for fruiting body content.
From Mechanism to Clinical Evidence
The mechanistic picture built from cell-culture studies connecting hericenone C to NGF synthesis finds its closest clinical parallel in the Mori 2009 randomized controlled trial.[6]
Mori and colleagues enrolled 30 patients with mild cognitive impairment (MCI) and randomized them to receive either 250 mg tablets of Hericium erinaceus powder (three tablets taken three times daily, totaling 750 mg powder) or placebo for 16 weeks. The Lion's Mane group showed statistically significant improvement on cognitive function scores compared to placebo (p<0.001). The improvements declined after supplementation stopped, which is consistent with an ongoing biological effect rather than a permanent structural change.
The Mori 2009 trial used fruiting body powder, the same tissue where hericenones are found. This does not prove that hericenone C specifically was responsible for the cognitive effects observed — many other compounds are present in fruiting body extract, and the mechanism connection to hericenone C requires several inferential steps from cell culture to clinical outcome. But the trial does establish that there is human evidence for cognitive effects from the tissue that contains the compounds the mechanistic research points toward.
A 2018 review by Roda and colleagues covering the neurohealth properties of Hericium erinaceus provides additional mechanistic synthesis, confirming that the erinacines (from mycelium) add a complementary pathway via direct BBB penetration and NGF synthesis in neural tissue, while hericenones operate through the astrocyte secretion route.[7] For more on how erinacines cross the blood-brain barrier and what they do once inside, see How Erinacines Cross the Blood-Brain Barrier.
For the complete NGF research context covering all of Lion's Mane's neurotrophic effects, see Lion's Mane and Nerve Growth Factor: The Complete Research Guide. For a second neurotrophic pathway discovered beyond NGF, see Lion's Mane and Progranulin: A Second Neurotrophic Pathway Beyond NGF.
The Bottom Line
Hericenone C is an aromatic meroterpenoid from Lion's Mane fruiting body that stimulates NGF synthesis in astrocyte brain cells via MEK/ERK and PI3K/Akt signaling. Quantitatively, it produces 23.5 pg/mL NGF in cell culture — potent enough to synergize with low-dose exogenous NGF to produce effects matching 10x the applied NGF alone. Two major updates in recent years changed the field: a 2021 total synthesis corrected 30 years of incorrect structural data, and a 2023 study found that hericerin derivatives activate a pan-neurotrophic ERK1/2 pathway directly in hippocampal neurons without requiring NGF protein as intermediary, improving spatial memory in rodents.
Frequently Asked Questions
Sources & References
- 1. Source details for this reference are not yet available.
- 2. Source details for this reference are not yet available.
- 3. Source details for this reference are not yet available.
- 4. Source details for this reference are not yet available.
- 5. Source details for this reference are not yet available.
- 6. Source details for this reference are not yet available.
- 7. Source details for this reference are not yet available.
- 8. Source details for this reference are not yet available.